For further details see:
Nabriva antibiotic meets primary endpoint in phase 3 trial; shares soar 40%home / stock / dnpuf / dnpuf news
For further details see:
Nabriva antibiotic meets primary endpoint in phase 3 trial; shares soar 40%Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Dai Nippon Pharm Ord Company Name:
DNPUF Stock Symbol:
Market:
Kyoto, Japan, June 25, 2019 - (JCN Newswire) - Hacarus Inc, the leading provider of lightweight and explainable AI, was today awarded the Grand Prize by DS Pharma Animal Health for its innovative AI-enabled technology platform 'HACARUS.ai'. "It is a great honor to receive this award for our w...